Tetra Radar · FDA Approvals · Decision date

deramiocel: FDA decision date

Capricor Therapeutics, Inc. (CAPR) · 22 November 2026

Our BLA for Deramiocel remains under FDA review, with a PDUFA target action date of November 22, 2026.

Source: 10-Q of 10 November 2026

The decision is pending.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.